Modified Dose Intensive R- CODOX-M/IVAC for HIV-associated Burkitt (BL) (AMC 048) Shows Efficacy and Tolerability, and Predictive Potential of IRF4/MUM1 Expression
Infectious Agents and Cancer - United Kingdom
doi 10.1186/1750-9378-7-s1-o14
Full Text
Open PDFAbstract
Available in full text
Date
April 19, 2012
Authors
Publisher
Springer Science and Business Media LLC